Yuanqi Zhang
Zhanjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain : A Prospective, Randomized, Phase 3 Trial.
Journal: Annals of internal medicine
Published: March 23, 2026
Correction: Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances.
Journal: Frontiers in pharmacology
Published: February 14, 2026
Uric acid enhances tumor stemness in breast cancer cells by upregulating GMPS.
Journal: Molecular medicine reports
Published: November 18, 2025
Exploring neoadjuvant chemotherapy in a rare case of male breast cancer-a TEC-regimen (docetaxel, epirubicin, and cyclophosphamide) treatment: a case report and literature review.
Journal: AME case reports
Published: October 29, 2025
Association between baseline hemoglobin levels and pathological complete response in 404 female breast cancer patients undergoing neoadjuvant therapy in Western Guangdong region: a retrospective cohort study.
Journal: Frontiers in oncology
Published: September 04, 2025
Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.
Journal: Frontiers in nutrition
Published: August 19, 2025
The impact of serum interleukin-17a as a predictive biomarker for neoadjuvant therapy response in breast cancer: a retrospective study.
Journal: Gland surgery
Published: May 07, 2025
Potential role of AhR in ischemia‑reperfusion injury and cancers: Focus on ferroptosis and lipid peroxidation signaling pathways (Review).
Journal: International journal of molecular medicine
Published: March 05, 2025
A global bibliometric and visualized analysis of the status and trends of lung metastasis in breast cancer research from 2000 to 2024.
Journal: Discover oncology
Published: February 17, 2025
Reelin-LRP8 signaling mediates brain dissemination of breast cancer cells via abluminal migration.
Journal: EMBO molecular medicine
Published: December 10, 2024
Efficacy and safety of traditional Chinese medicine in managing bone loss post-endocrine therapy in hormone receptor-positive breast cancer patients.
Journal: Medicine
Published: October 28, 2024
Last Updated: 09/26/2026